Search Orphan Drug Designations and Approvals
-
Generic Name: | avexitide |
---|---|
Date Designated: | 12/08/2016 |
Orphan Designation: | Treatment of hyperinsulinemic hypoglycemia |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Eiger BioPharmaceuticals, Inc. 350 Cambridge Avenue Suite 350 Palo Alto, California 94306 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-